This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in


Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Tadalafil is a phosphodiesterase type 5 inhibitor (PDE5), like sidenafil.

  • the Summary of Product Characteristics states that (1):
    • men should be started on a dose of 10mg, taken at least 30 minutes prior to sexual activity
    • if the 10mg dose does not produce an adequate effect then the dose can be increased to 20mg
    • the maximum dosing is once daily - the mean half-life is 17.5 hours
    • continuous daily dosing is discouraged - safety of prolonged daily dosing has not been established
    • the Summary of Product Characteristics recommends a dose of 10mg for men with "impaired hepatic function" and a maximum dose of 10mg for those with "severe renal impairment"
  • focusing on its phase II/III trial results, tadalafil appears to have an enhanced period of responsiveness extending out to 36 hours in 60% of men using the 20 mg dose. Efficacy across a large population of men with erectile dysfunction (ED) of various causes (n = 1112) is in accordance with the other PDE5 inhibitors at 81% (1). Side effects are generally mild-to-moderate with study drop-out rate at 1.7% in the active arm compared to 1.1% among those receiving placebo (2)

The summary of product characteristics must be consulted before prescribing this drug


  1. Drug and Therapeutics Bulletin (2004); 42 (7): 49-52.
  2. Selective phosphodiesterase type 5 inhibition using tadalafil for the treatment of erectile dysfunction. Expert Opin Investig Drugs. 2002 Nov;11(11):1605-13.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.